Coppell Advisory Solutions LLC Arcellx, Inc. Transaction History

Coppell Advisory Solutions LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$31.51 - $37.4 $5,262 - $6,245	-167 Reduced 74.55%	57 $8 Million
Q2 2023 Aug 17, 2023	BUY	$27.49 - $46.9 $6,157 - $10,505	224 New	224 $35.5 Million
Q1 2023 May 19, 2023	SELL	$26.92 - $33.94 $2,853 - $3,597	-106 Closed	0 $0
Q4 2022 May 19, 2023	BUY	$17.18 - $33.0 $1,821 - $3,498	106 New	106 $14.9 Million

204

44.2M

2.23M

907K

Ticker ACLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,819,200
Market Cap $3.43B
Description
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

Stay updated on Coppell Advisory Solutions LLC with notifications on news.